About
Antibody Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySan Diego & Southern California
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,254
By Phase
PHASE2: 8
By Status
COMPLETED: 5ACTIVE_NOT_RECRUITING: 2TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06127043Lead Sponsor
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
PHASE2Active, not recruiting
132 participants
Started: Dec 4, 2023 · Completed: May 31, 2026
NCT06041269Lead Sponsor
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)
PHASE2Active, not recruiting
420 participants
Started: Aug 31, 2023 · Completed: May 30, 2025
NCT05935085Lead Sponsor
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).
PHASE2Terminated
201 participants
Started: Jun 13, 2023 · Completed: Jan 7, 2025
NCT05205070Lead Sponsor
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
PHASE2Unknown
45 participants
Started: Dec 22, 2021 · Completed: Mar 19, 2023
NCT03614923Lead Sponsor
Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
PHASE2Completed
105 participants
Started: Nov 29, 2018 · Completed: Oct 26, 2020
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...